Terumo and Daiichi Sankyo partner to support cardiovascular care in Vietnam

Terumo Vietnam Medical Equipment (Terumo Vietnam) and Daiichi Sankyo Vietnam have signed a Memorandum of Understanding (MoU) to collaborate on advancing cardiovascular expertise in Vietnam.

Cardiovascular disease remains a significant health challenge in Vietnam, highlighting the need for ongoing education and training in diagnosis and intervention. Under the MoU, Terumo Vietnam and Daiichi Sankyo Vietnam plan to implement various initiatives, including scientific symposia, hands-on workshops, and continuous medical education (CME) sessions conducted both in person and online. Additionally, the partnership will focus on enhancing multidisciplinary team (MDT) workflows at comprehensive interventional cardiovascular centers and fostering collaboration between international and local medical institutions.

Terumo Vietnam specializes in medical devices, while Daiichi Sankyo Vietnam is known for its expertise in pharmaceutical therapies, particularly in antiplatelet treatments. Through this collaboration, both companies aim to support the management of acute coronary syndrome (ACS) in patients undergoing percutaneous coronary intervention (PCI). The joint efforts will focus on enhancing PCI knowledge and techniques, strengthening coordination between departments such as emergency care (ER), intensive care units (ICU), and outpatient services, and improving post-PCI care and follow-up.

“This partnership reflects a commitment to supporting healthcare providers,” said Gaurav Chhillar, General Director of Terumo Vietnam Medical Equipment. “By working together, we hope to contribute to improved clinical decision-making and better treatment outcomes for cardiovascular patients.”

The MoU is part of broader efforts by both companies to support Vietnam’s healthcare system through education, mentorship, and professional development initiatives.